Replies to post #252455 on Innovation Pharmaceuticals Inc (IPIX)

[scottsmith]

You don’t think Art and Jane are up close and personal with the beakers? Yea, not do I. I’m fascinated to see how much longer those two remain ipix employees and where Art lands next. Lately Art has gone from big pharma to micro cap to nano cap.

[Yooper61]

Good post. In the void of information, I can no longer assume good business judgement. I’m dumbfounded by the Aspire milestone miss and now the P failure.

I never invested a dime for P science, but I did invest for my false assumption of good business sense. Especially from a Michigan MBA. The Case Report Forms should have given them evidence to base the decision to forego the interim look. I was in the camp, if in doubt take the planned interim look. Around the same time, Protagonist took an interim look at 65 patients in a 200+ patient trial. They stopped the trial and saved their stock holders millions. Our management teams decision cost us millions we didn’t have, dilution, poor bargaining position on B-OM, and stockholders holding their breath to see if the show is over.

Spending $1M on drug manufacturing or $19k a month on 12,000 square feet is not something a reasonable business person would dilute stockholders for, unless their was an appropriate, timely need to so. But these could just be more bone head decisions.